NCT04588467

Brief Summary

Thrombosis of the external hemorrhoids (TEH) is one of the most frequent complain during pregnancy, particularly during the third trimester. The paucity of the medical literature on this topic has recently been underlined in the European guidelines for hemorrhoid treatment . The aim of this prospective study is to compare the efficacy and safety of conservative versus surgical treatment of TEH in pregnant women

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2020

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 8, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 19, 2020

Completed
Last Updated

October 19, 2020

Status Verified

October 1, 2020

Enrollment Period

1.2 years

First QC Date

October 8, 2020

Last Update Submit

October 14, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain evaluation: scale

    A scale of pain will be administered to patients

    10 days

  • Quality of Life evaluation: questionnaire

    A questionnaire of quality of life will be administered to patients after the treatment

    10 days

Study Arms (2)

Conservative group

ACTIVE COMPARATOR

Conservative treatment included dietary modification (intake of at lest 3 liters of water), stool-softeners (a 25 ml solution containing: Macrogol 3350: 13.125 g Sodium chloride: 0.3508 g Sodium hydrogen carbonate: 0.1786 g Potassium chloride: 0.0502 g) and local anesthetics application (Lidocaine 2.5%+Prilocaine 2.5%, 2g twice a day) for 10 days

Other: Medical treatment

Surgical group

EXPERIMENTAL

Thrombectomy and local excision of external hemorrhoids were performed with the patient in the lithotomy position under local infiltrative anesthesia with UltracainDS 1:200000 1.7ml

Procedure: Surgical treatment

Interventions

Pregnant women complaining thrombosed haemorrhoids will receive dietary modification (intake of at lest 3 liers of water), stool-softeners (a 25 ml solution containing: Macrogol 3350: 13.125 g Sodium chloride: 0.3508 g Sodium hydrogen carbonate: 0.1786 g Potassium chloride: 0.0502 g) and local anesthetics application

Conservative group

Pregnant women complaining thrombosed haemorrhoids will receive local excision or thrombectomy under local anesthesia

Surgical group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnancy
  • Thrombosed external haemorrhoids
  • Written consent

You may not qualify if:

  • Inflammatory bowel disease
  • Cancer
  • Age lower than 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Colorectal and Minimally invasive surgery

Moscow, 119435, Russia

Location

Related Publications (1)

  • Medkova Y, Tulina I, Novikov I, Nikonov A, Ischenko A, Aleksandrov L, Altomare DF, Dezi A, Picciariello A, Tsarkov P. Thrombosed external hemorrhoids during pregnancy: surgery versus conservative treatment. Updates Surg. 2024 Apr;76(2):539-545. doi: 10.1007/s13304-023-01741-y. Epub 2023 Dec 27.

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Officials

  • Inna Tulina, Prof

    Russian Society of Colorectal Surgeons

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2020

First Posted

October 19, 2020

Study Start

January 2, 2019

Primary Completion

March 2, 2020

Study Completion

October 2, 2020

Last Updated

October 19, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations